63N.F Stock Analysis
63
Uncovered
Bimi International Medical Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
BIMI International Medical, Inc. engages in the provision of healthcare products and services. The company is headquartered in Chongqing, Chongqing and currently employs 524 full-time employees. The company went IPO on 2010-10-04. The firm mainly conducts its businesses through four segments. The Wholesale Pharmaceutical segment provides prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. The Wholesale Medical Device segment distributes medical devices, including medical consumables to private clinics, hospitals, third party pharmacies and other medical device dealers. The Medical Service segment include private comprehensive hospitals operating in China. The Retail Pharmacy segment sells prescription and OTC medicines, TCM, healthcare supplies and sundry items to retail customers.